Torrent Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, declared Select Dividend of Rs. 9 per equity share.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals reported standalone net profit of Rs. 2,192 crores for FY26, up 16% from Rs. 1,888 crores in FY25. Revenue from operations grew to Rs. 10,498 crores from Rs. 9,485 crores. The Board declared a final dividend of Rs. 9 per share (180% on face value Rs. 5), adding to the Rs. 29 interim dividend already paid, totaling Rs. 38 per share for the year. The Board also sought shareholder approval for issuing equity/convertible instruments up to Rs. 5,000 crores via QIP. The auditors gave an unmodified (clean) opinion on the financial statements. The company completed its major acquisition of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) in January 2026 for approximately Rs. 12,537 crores, gaining control over the subsidiary.
Strong financial performance with 16% profit growth and increased total dividend (Rs. 38 vs Rs. 35 last year) is positive for shareholders. The QIP approval provides flexibility for future capital raising but could dilute existing shareholder value depending on issuance terms and pricing.